NEW YORK: Pfizer Inc, which is in the process of trying to acquire British rival AstraZeneca for more than US$100 billion, on Friday said it planned to seek U.S. approval for palbociclib, its experimental drug for advanced breast cancer, in the third quarter.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!